PATH | VRL
Menu

Find resources

Total results with these characteristics: 118

Disease: Japanese encephalitis

Page 5 of 6
Post-Marketing Safety Surveillance for Inactivated and Live-Attenuated Japanese Encephalitis Vaccines in China, 2008–2013

This article, published in Vaccine, presents the results of passive post-marketing safety surveillance for an inactivated Japanese encephalitis (JE) vaccine and a live-attenuated JE vaccine in China from 2008 to 2013. Passive surveillance of …

Author: Wu W, Liu D, Li K, et al.

Publication date: 2017

Protecting Aluminum-Adjuvanted Vaccines From Freeze Damage

This fact sheet describes how PATH developed a low-cost and straightforward technology for protecting aluminum-adjuvanted liquid vaccines from the irreversible damage that results from freezing. Many current vaccines of importance to global health …

Author: PATH

Publication date: 2012

Protecting Asia's Children

This article featured in PATH’s programmatic newsletter, Directions in Global Health, discusses PATH's JE project and their work in Asia.

Author: PATH

Publication date: 2005

Protecting India's Children from Japanese Encephalitis

This fact sheet provides information about the partnerships and commitments that helped the Government of India introduce a landmark strategy to vaccinate children at highest risk. Campaigns in 2006 reached more than 9 million, and the target …

Author: PATH

Publication date: 2007

Protection Against Japanese Encephalitis by Inactivated Vaccines

Published in the New England Journal of Medicine, this evaluation of two doses of monovalent and bivalent inactivated mouse brain-derived JE vaccines in a northern Thai province found a combined rate of 91% efficacy. ABSTRACT ONLY. (Learn how users …

Author: Hoke C, Nisalak A, Sangawhipa N, et al.

Publication date: 1988

Protection of SA 14-14-2 Live Attenuated Japanese Encephalitis Vaccine Against the Wild-Type JE Viruses

Published in the Chinese Medical Journal, this study found the SA 14-14-2 vaccine to be broadly immunogenic and protective against several strains of JE endemic to Asia.

Author: Jia L, Wang Z, Yu Y

Publication date: 2003

Public Assessment Summary Report – Japanese Encephalitis Vaccine, Live (Human)

This document provides a summary of a live attenuated Japanese encephalitis vaccine, including information on the use of the vaccine, dosing, formulation, and safety and immunogenicity results from clinical trials.

Author: World Health Organization

Publication date: 2013

PubMed Searches: Japanese Encephalitis

These pre-formatted searches will retrieve journal citations and availalbe abstracts on JE. Documents may be ordered through Loansome Doc if you have established an agreement with a participating library. See the "registration button" on …

Author: Various

The Rationale for Integrated Childhood Meningoencephalitis Surveillance: A Case Study From Cambodia

This paper, published in The Bulletin of the World Health Organization, provides an example of development of an integrated meningoencephalitis surveillance system in Cambodia and, on the basis of this case study, presents the rationale and …

Author: Touch S, Grundy J, Hills S, et al.

Publication date: 2009

Report on "Consultative Meeting on Japanese Encephalitis (JE) Prevention and Control"

The Consultative Meeting on JE Prevention and Control was convened by the Institute of Epidemiology, Disease Control and Research (IEDCR) in Dhaka, Bangladesh, on February 12. This official meeting record includes participants, objectives, and …

Author: Institute of Epidemiology, Disease Control & Research

Publication date: 2009

Report on the Japanese Encephalitis Disability Assessment

The burden of disability among JE survivors has been a neglected area of study. This assessment, performed by the Government of Cambodia in partnership with PATH, found one in four children infected with JE either died or suffered severe sequelae …

Author: Cambodian Ministry of Health

Publication date: 2008

SA 14-14-2 Live Japanese Encephalitis (JE) Vaccine

This fact sheet provides important information on the SA 14-14-2 JE vaccine manufactured by the Chengdu Institute of Biological Products in China. Topics include vaccine presentation, dosage, safety, and history of use.

Author: PATH

Publication date: 2013

Safety and Immunogenicity of a Vero-cell-Derived, Inactivated Japanese Encephalitis Vaccine: A Non-inferiority, Phase III, Randomised Controlled Trial

Published in The Lancet, this study demonstrates a strong immunogenicity and safety profile among adults for a JE vaccine under development by Intercell. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal …

Author: Tauber E, Kollaritsch H, Korinek M, et al.

Publication date: 2007

Safety and Immunogenicity of Concomitant Vaccination With the Cell-Culture Based Japanese Encephalitis Vaccine IC51 and the Hepatitis A Vaccine HAVRIX1440 in Healthy Subjects: A Single-Blind, Randomized, Controlled Phase 3 Study

In travelers often several pre-departure immunizations are indicated, thus data are needed about possible interactions between vaccines. This Phase 3 study investigated the immunogenicity and safety of IC51 (JE vaccine) and HAVRIX1440 (hepatitis A …

Author: Kaltenböck A, Dubischar-Kastner K, Eder G, et al.

Publication date: 2009

Safety and Immunogenicity of Live-Attenuated Japanese Encephalitis SA 14-14-2 Vaccine Co-Administered With Measles Vaccine in 9-Month-Old Infants in Sri Lanka

This article, published in Vaccine, examines the safety and immunogenicity of live attenuated Japanese encephalitis vaccine (LJEV) when administered with measles vaccine in nine-month-old Sri Lankan infants. The results support the use of LJEV at …

Author: Wijesinghe PR, Abeysinghe MRN, Yoksan S, et al.

Publication date: 2014

Sentinel Site Surveillance of Japanese Encephalitis

These guidelines were developed to assist program managers considering the implementation of JE sentinel site surveillance.

Author: PATH

Publication date: 2006

Sentinel Surveillance for Japanese Encephalitis: Fact Sheet

This document outlines the rationale and summarizes considerations for sentinel surveillance of JE disease burden.

Author: PATH

Publication date: 2007

Shadow Lives: The Human Toll of Japanese Encephalitis

Children who survive JE infection must come to grips with the human and socioeconomic consequences of the disease. Produced in collaboration with the JE Project, Shadow Lives—The Human Toll of Japanese Encephalitis, introduces us to families who …

Author: PATH

Publication date: 2006

Short-term Safety of Live Attenuated Japanese Encephalitis Vaccine (SA 14-14-2): Results of a Randomized Trial with 26,239 Subjects

Published in the Journal of Infectious Diseases, this study evaluated the occurrence of severe adverse events among children immunized with the live, attenuated SA 14-14-2 JE vaccine for 30 days, and data demonstrated short-term safety of the …

Author: Liu Z-L, Hennessy S, Strom B, et al.

Publication date: 1997

Single Dose of SA 14-14-2 Vaccine Provides Long-term Protection Against Japanese Encephalitis: A Case-control Study in Nepalese Children 5 Years After Immunization

Published in the journal Vaccine, this article discusses the return of investigators to Nepali villages where they conducted a case control study that revealed 99 percent efficacy after one year among children who received a single dose of the …

Author: Tandan J, Ohrr H, Sohn Y, et al.

Publication date: 2007

Page 5 of 6